Chronic Invasive Sinus Aspergillosis in Immunocompetent Hosts: A Geographic Comparison

Mycopathologia

Volumn 170, Issue 6, 2010, Pages 403-410

  Webb, Brandon J ^a   Vikram, Holenarasipur R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aspergillus; Chronic invasive; Fungal; Immunocompetent; Sinusitis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CYTOCHEMISTRY; FEMALE; GEOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MALE; META ANALYSIS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NORTH AMERICA; PARANASAL SINUS DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; FEMALE; GEOGRAPHY; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; PARANASAL SINUS DISEASES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; YOUNG ADULT;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS;

EID: 78049332020     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-010-9338-x     Document Type: Article

References (53)

1. Siddiqui AA, Shah AA, Bashir SH, Siddiqui AA, et al. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases. Neurosurgery. 2004; 55: 602-11.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998; 26: 781-803.
3. Clancy CJ, Nguyen MH. Invasive sinus aspergillosis in apparently immunocompetent hosts. J Infect. 1998; 37: 229-40.
4. Heier JS, Gardner TA, Hawes MJ, et al. Proptosis as the initial presentation of fungal sinusitis in immunocompetent patients. Ophthalmology. 1995; 102: 713-7.
5. Johnson CD, Brandes W, Johnson CD, et al. Invasive aspergillosis of the sphenoethmoidal sinuses in an immunocompetent host. J Am Osteopathic Assoc. 1992; 92: 1047-51.
6. Mauriello JA Jr, Yepez N, Mostafavi R, et al. Invasive rhinosino-orbital aspergillosis with precipitous visual loss. Can J Ophthalmol. 1995; 30: 124-30.
7. Sarti EJ, Blaugrund SM, Lin PT, et al. Paranasal sinus disease with intracranial extension: Aspergillosis versus malignancy. Laryngoscope. 1988; 98: 632-5.
8. Stringer SP, Ryan MW, Stringer SP, et al. Chronic invasive fungal rhinosinusitis. Otolaryngol Clin North Am. 2000; 33: 375-87.
9. Washburn RG, Kennedy DW, Begley MG, et al. Chronic fungal sinusitis in apparently normal hosts. Medicine. 1988; 67: 231-47.
10. Sivak-Callcott JA, Livesley N, Nugent RA, et al. Localised invasive sino-orbital aspergillosis: characteristic features. British J Ophthalmol. 2004; 88: 681-7.
11. Yu VL, Wagner GE, Shadomy S. Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin b and surgery. JAMA. 1980; 244: 814-5.
12. Bradley SF, McGuire NM, Kauffman CA. Sino-orbital and cerebral aspergillosis: cure with medical therapy. Mykosen. 1987; 30: 379-85.
13. Fuchs HA, Evans RM, Gregg CR. Invasive aspergillosis of the sphenoid sinus manifested as a pituitary tumor. South Med J. 1985; 78: 1365-7.
14. Chopra H, Dua K, Malhotra V. Invasive fungal sinusitis of isolated sphenoid sinus in immunocompetent subjects. Mycoses. 2006; 49: 30-6.
15. De Foer C, Fossion E, Vaillant JM. Sinus aspergillosis. J Craniomaxillofac Surg. 1990; 18: 33-40.
16. Hakim SM, Milne LJ, Fox C, et al. Management of invasive aspergillosis with itraconazole. Br J Clin Pract. 1993; 47: 312-4.
17. Kameswaran M, al-Wadei A, Khurana P, et al. Rhinocerebral aspergillosis. J Laryngol Otol. 1992; 106: 981-5.
18. Naim Ur R, Jamjoom A, al-Hedaithy SS, et al. Cranial and intracranial aspergillosis of sino-nasal origin. Report of nine cases. Acta Neurochir. 1996; 138: 944-50.
19. Oates J, Clark DR, Chiodini P, et al. Intracranial extension of paranasal sinus aspergillosis. J Laryngol Otol. 1987; 101: 188-90.
20. Rowe-Jones JM, Freedman AR. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis. Rhinology. 1994; 32: 203-7.
21. Subramanian S, Kandpal H, Sharma R, et al. Invasive sinus aspergillosis with perineural spread in an immunocompetent patient. Australas Radiol. 2007; 51(Suppl): B189-92.
22. Akhaddar A, Gazzaz M, Albouzidi A, et al. Invasive Aspergillus terreus sinusitis with orbitocranial extension: case report. Surg Neurol. 2008; 69: 490-5.
23. Baumann A, Zimmerli S, Hausler R, et al. Invasive sphenoidal aspergillosis: successful treatment with sphenoidotomy and voriconazole. ORL J Otorhinolaryngol Relat Spec. 2007; 69: 121-6.
24. Kurita H, Shiokawa Y, Furuya K, et al. Parasellar Aspergillus granuloma extending from the sphenoid sinus: report of two cases. Surg Neurol. 1995; 44: 489-94.
25. Lowe J, Bradley J. Cerebral and orbital aspergillus infection due to invasive aspergillosis of ethmoid sinus. J Clin Pathol. 1986; 39: 774-8.
26. Notani K, Satoh C, Hashimoto I, et al. Intracranial aspergillus infection from the paranasal sinus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89: 9-11.
27. Sood S, Sharma R, Gupta S, et al. Neuroaspergillosis in an immunocompetent patient. Indian J Med Microbiol. 2007; 25: 67-9.
28. Suzuki K, Iwabuchi N, Kuramochi S, et al. Aspergillus aneurysm of the middle cerebral artery causing a fatal subarachnoid hemorrhage. Intern Med. 1995; 34: 550-3.
29. Yumoto E, Kitani S, Okamura H, et al. Sino-orbital aspergillosis associated with total ophthalmoplegia. Laryngoscope. 1985; 95: 190-2.
30. Mneimneh W, Cazals-Hatem D, Mosnier I, et al. Indolent invasive sphenoid aspergillosis mimicking a neoplastic process. Histopathology. 2006; 49: 210-1.
31. Panda NK, Saravanan K, Chakrabarti A. Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base? Am J Otolaryngol. 2008; 29: 24-30.
32. Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008; 46: 201-11.
33. Yamanoi T, Shibano K, Soeda T, et al. Intracranial invasive aspergillosis originating in the sphenoid sinus: a successful treatment with high-dose itraconazole in three cases. Tohoku J Exp Med. 2004; 203: 133-9.
34. deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med. 1997; 337: 254-9.
35. Chakrabarti ADA, Panda NK. Controversies surrounding the categorization of fungal sinusitis. Medical Mycol. 2008; 47(Suppl 1): s299-308.
36. Adelson RT, Marple BF, Adelson RT. State-of-the-art diagnosis and treatment. J Otolaryngol. 2005; 34(Suppl 1): S18-23.
37. McGill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope. 1980; 90: 748-54.
38. deShazo RD, O'Brien M, Chapin K. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997; 123: 1181-8.
39. Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope. 2009; 119(9): 1809-18.
40. Alrajhi AA, Enani M, Mahasin Z, Al-Omran K, et al. Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg. 2001; 65: 83-6.
41. Veress B, Malik OA, el-Tayeb AA, et al. Further observations on the primary paranasal Aspergillus granuloma in the sudan: a morphological study of 46 cases. Am J Trop Med Hyg. 1973; 22: 765-72.
42. Hedayati MT, Pasqualotto AC, Warn PA, et al. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007; 153: 1677-92.
43. Hohl TM, Feldmesser M. Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryot Cell. 2007; 6: 1953-63.
44. Leenders AC, van Belkum A, Behrendt M, et al. Density and molecular epidemiology of aspergillus in air and relationship to outbreaks of aspergillus infection. J Clin Microbiol. 1999; 37: 1752-7.
45. Mallea M, Murray IG, Segretain G, et al. Census of aspergillus colonies in the air comparison between London, Paris, Lyon, Marseilles. Acta Allergol. 1972; 27: 273-8.
46. Vanbreuseghem R, Nolard N. Variations in fungal spores in the air during the last 10 years in belgium. Bull Mem Acad R Med Belg. 1985; 140: 147-8.
47. Abdalla MH. Prevalence of airborne Aspergillus flavus in khartoum (Sudan) airspora with reference to dusty weather and inoculum survival in simulated summer conditions. Mycopathologia. 1988; 104: 137-41.
48. Adhikari A, Sen MM, Gupta-Bhattacharya S, et al. Airborne viable, non-viable, and allergenic fungi in a rural agricultural area of India: a 2-year study at five outdoor sampling stations. Sci Total Environ. 2004; 326: 123-41.
49. Gallin JI, Zarember K. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease. Trans Am Clin Climatol Assoc. 2007; 118: 175-85.
50. Seifert M, Nairz M, Schroll A, Schrettl M, Haas H, Weiss G. Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology. 2008; 213: 767-78.
51. Segal BH. Aspergillosis. N Engl J Med. 2009; 360: 1870-84.
52. Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol. 2009; 47(Suppl 1): S261-70.
53. Herbrecht R, Denning DW, Patterson TF, et al. Invasive fungal infections group of the European organisation for research and treatment of cancer and the global aspergillus study g: voriconazole versus amphotericin b for primary therapy of invasive aspergillosis. N Engl J Med. 2002; 347: 408-15.